Miracor Medical is a pioneering medical device company dedicated to developing innovative solutions for treating severe heart diseases. The company is headquartered in Awans, Belgium, and operates within the healthcare sector, specifically focusing on cardiac care. Miracor Medical's flagship product is the PiCSO (Pressure-controlled Intermittent Coronary Sinus Occlusion) system, a novel therapy designed to be used during percutaneous coronary intervention (PCI) procedures. PCI is a non-surgical method used to treat narrowing of the coronary arteries of the heart found in heart disease patients.

The PiCSO system aims to improve outcomes for patients suffering from Acute Myocardial Infarction (MI), commonly known as a heart attack. By intermittently occluding (blocking) the coronary sinus, the PiCSO system enhances blood flow and reduces damage to the heart muscle during and after a heart attack. This technology is intended to be a first-line therapy, meaning it is used as an initial treatment to improve patient outcomes significantly.

Miracor Medical's primary clients are hospitals and healthcare providers specializing in cardiac care. The company operates in the global medical device market, which is characterized by rapid technological advancements and a high demand for innovative treatments for heart diseases.

The business model of Miracor Medical revolves around the development, approval, and commercialization of its medical devices. The company generates revenue through the sale of its PiCSO system, which includes the PiCSO Impulse Catheter and Console. The recent awarding of the CE Mark for this system indicates that it meets European health, safety, and environmental protection standards, allowing it to be marketed and sold within the European Economic Area.

In summary, Miracor Medical is focused on delivering clinically effective technology to improve the lives of patients with cardiac diseases. The company makes money by selling its innovative PiCSO system to healthcare providers, aiming to set a new standard in the treatment of heart attack patients.

Keywords: Medical Devices, Cardiac Care, Heart Disease, PiCSO, PCI, Acute Myocardial Infarction, Innovation, Healthcare, CE Mark, Revenue.